Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?

Endri Mauro; P. Passadore; L. Quartuccio; S. De Vita; A. Ermacora; V. Gattei; C. Mazzaro

Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?

Endri Mauro, P. Passadore, L. Quartuccio, S. De Vita, A. Ermacora, V. Gattei, C. Mazzaro

Centro di Riferimento Oncologico

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	672-673
Number of pages	2
Journal	Acta Gastro-Enterologica Belgica
Volume	83
Issue number	4
Publication status	Published - Oct 1 2020

ASJC Scopus subject areas

Gastroenterology

Cite this

Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related : Always correct therapeutic approach? / Mauro, Endri; Passadore, P.; Quartuccio, L.; De Vita, S.; Ermacora, A.; Gattei, V.; Mazzaro, C.

In: Acta Gastro-Enterologica Belgica, Vol. 83, No. 4, 01.10.2020, p. 672-673.

Research output: Contribution to journal › Letter › peer-review

@article{17c344993ff84cf2b62ca843fdae1c21,

title = "Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?",

author = "Endri Mauro and P. Passadore and L. Quartuccio and {De Vita}, S. and A. Ermacora and V. Gattei and C. Mazzaro",

year = "2020",

month = oct,

day = "1",

language = "English",

volume = "83",

pages = "672--673",

journal = "Acta Gastro-Enterologica Belgica",

issn = "0001-5644",

publisher = "Universa Press",

number = "4",

}

TY - JOUR

T1 - Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related

T2 - Always correct therapeutic approach?

AU - Mauro, Endri

AU - Passadore, P.

AU - Quartuccio, L.

AU - De Vita, S.

AU - Ermacora, A.

AU - Gattei, V.

AU - Mazzaro, C.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85098533602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098533602&partnerID=8YFLogxK

M3 - Letter

C2 - 33321031

AN - SCOPUS:85098533602

VL - 83

SP - 672

EP - 673

JO - Acta Gastro-Enterologica Belgica

JF - Acta Gastro-Enterologica Belgica

SN - 0001-5644

IS - 4

ER -

Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?

ASJC Scopus subject areas

Other files and links

Cite this